TIC.NYSEAcuren CORP

Form 4: ACUREN Director Byron Roth Granted 9,524 RSUs

Sentiment:

Insider Transaction Report


ACUREN Corp. Director Byron Roth was granted 9,524 restricted stock units, which will vest on August 4, 2026.

Summary

  • Director Byron Roth of ACUREN Corp. was granted 9,524 Restricted Stock Units (RSUs) on August 4, 2025.
  • Each RSU represents a contingent right to receive one share of ACUREN's Common Stock.
  • The acquisition price for these RSUs was $0.00, indicating a grant rather than a purchase.
  • These restricted stock units are scheduled to vest on August 4, 2026, which is the one-year anniversary of the grant date.
  • Following this transaction, Byron Roth beneficially owns 9,524 restricted stock units directly.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive sign of aligning management interests with shareholder value, promoting long-term commitment. It is a routine compensation event.

Positives

  • The grant of restricted stock units to a director aligns their interests with shareholders, promoting long-term commitment and performance.
  • The vesting schedule encourages retention and continued contribution from the director.

Negatives

  • No immediate cash inflow for the director from this grant, as it represents restricted stock units that vest in the future.
  • Potential for minor dilution for existing shareholders upon the future vesting and conversion of RSUs into common stock, which is standard for equity compensation.

Risks

  • The restricted stock units are a contingent right and do not represent immediate ownership of common stock until they vest on August 4, 2026.

Future Outlook

The 9,524 restricted stock units are scheduled to vest on August 4, 2026, which is the one-year anniversary of the grant date, indicating a future conversion to common stock.

Industry Context

The grant of restricted stock units to a director is a standard practice in corporate compensation across various industries, aligning executive incentives with long-term shareholder value creation.

Comparison to Industry Standards

  • Equity compensation through restricted stock units is a widely adopted practice for director remuneration across publicly traded companies, comparable to practices seen in technology, healthcare, and industrial sectors, where long-term incentives are used to retain talent and align interests.

Related Party Transactions

  • The grant of 9,524 restricted stock units to Byron Roth, a director of ACUREN Corp., constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

  • Shareholders: Potential minor dilution upon vesting, but improved alignment of director's interests with long-term shareholder value.
  • Employees: No direct impact mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

  • The 9,524 restricted stock units are scheduled to vest on August 4, 2026.

Key Dates

DateDescription
08/04/2025Date of grant for 9,524 Restricted Stock Units to Director Byron Roth.
08/06/2025Date the Form 4 was signed by Attorney-in-Fact MaryJo Obrien.
08/04/2026Vesting date for the 9,524 Restricted Stock Units granted to Director Byron Roth.

Keywords

ACUREN Corp, TIC, Form 4, Restricted Stock Units, RSU, Insider Trading, Director Compensation, Equity Grant, Byron Roth

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.